Why Pharmaceutical Cleanrooms Put 50-75% of Power Into HVAC

BS EN ISO 14644-16 benchmarks fan energy and airflow against ISO performance requirements.

Pharmaceutical HVAC energy efficiency reduces cleanroom heating, cooling, humidification, filtration and fan energy while maintaining the GMP-qualified environmental conditions that protect product quality. A 2019 Energy and Buildings study found that pharmaceutical cleanrooms can require 1.52 kW/m², compared with 0.06 kW/m² for non-classified rooms, and that HVAC commonly accounts for 50 to 75% of cleanroom electricity use.

That intensity follows from the system’s job. A cleanroom HVAC installation continuously moves, filters, cools, heats, dries or humidifies large volumes of air. It maintains controlled pressure relationships between rooms and supports particle control, recovery after activity and the protection of exposed product.

For sterile manufacture, these duties sit within the contamination control strategy. The energy bill is therefore tied to a verified quality function. Facilities teams can reduce demand, but every change must preserve the qualified state.

Why pharmaceutical cleanroom HVAC uses so much electricity

High airflow creates a large fan load

Airflow is the dominant driver. Supply fans must overcome resistance through air handling units, coils, pre-filters, HEPA filters, ductwork, terminal devices, room returns and extract paths. A cleanroom also needs sufficient airflow to dilute and remove contamination, achieve the required recovery performance and maintain the intended airflow pattern around the process.

The fan does this work around the clock. Many facilities keep air handling units at full duty through nights, weekends, maintenance windows and other at-rest periods. This can leave substantial avoidable fan energy in the baseline, particularly where airflow was set conservatively during design and has not been reassessed against actual operations.

High-efficiency particulate air filtration adds necessary pressure drop. Filter loading increases that resistance over time, so the fan system needs enough available pressure and suitable control to sustain specified room conditions as filters age. The result is a continuous electrical load unlike conventional commercial-building ventilation.

Conditioning outdoor and recirculated air adds thermal demand

The HVAC system must also manage sensible and latent loads. Outdoor air needs treatment before entering the controlled environment. Recirculated air absorbs heat from people, process equipment, lighting, motors and fan heat, then returns to the air handling unit for further conditioning.

Relative-humidity control can be particularly energy intensive. In humid weather, cooling coils often remove moisture by cooling air below its dew point. The system may then need reheating to deliver air at the specified supply condition. This protects the room setpoint, but can create simultaneous cooling and heating demand.

Pressure cascades introduce further energy use. A positive-pressure cleanroom needs enough filtered supply air, relative to return and extract air, to prevent ingress from lower-grade adjacent areas. Rooms used for containment may require the opposite relationship, based on the process risk assessment. Either arrangement needs stable control through door openings, operator movement and changes in equipment state.

The system operates to qualified performance, not comfort preference

The purpose of a pharmaceutical cleanroom is controlled contamination risk. EU GMP Annex 1 requires cleanroom and clean-air-equipment qualification appropriate to the installation and intended use. Qualifying tests can include installed-filter leakage and integrity, airflow volume and velocity, pressure differences, airflow direction and visualisation, microbial contamination, temperature, relative humidity, recovery and containment leakage.

These conditions are connected. Lowering supply airflow may reduce fan power, but it can also change terminal velocities, room pressure, recovery time and the sweep of first air across exposed product. Changing temperature or humidity setpoints can alter coil load, microbial-risk controls, product requirements and operator conditions.

Pharmaceutical HVAC energy efficiency therefore begins with evidence, not a blanket air-change-rate reduction.

What EU GMP Annex 1 means for energy optimisation

Annex 1 makes performance verification central

Most provisions of EU GMP Annex 1, Manufacture of Sterile Medicinal Products, became applicable on 25 August 2023; paragraph 8.123 became applicable on 25 August 2024. It requires manufacturers to establish environmental control through qualification, monitoring and documented risk management.

For unidirectional airflow systems, Annex 1 gives a guidance air-speed range of 0.36 to 0.54 m/s at the working position, unless the contamination control strategy scientifically justifies another value. Airflow visualisation studies should correlate with air-speed measurements. The design aim is product protection at the point of risk, rather than a nominal airflow figure in isolation.

Annex 1 gives 20 minutes as guidance for the clean-up period. The manufacturer must determine that period during room qualification, document it and apply it in procedures used to reinstate the qualified cleanliness state after disruption. This puts recovery performance at the centre of any airflow-reduction proposal.

Requalification defines the proof required after change

A change to HVAC operating parameters can affect the qualified state. Annex 1 identifies changes to cleanroom design or HVAC operational settings as examples requiring assessment through change management. Appropriate requalification follows where the impact warrants it.

The minimum requalification content includes cleanroom classification, final-filter integrity, airflow volume, pressure-difference verification and either air-velocity or recovery testing, according to room design and risk assessment. Grade A and B areas have a maximum requalification interval of six months. Grade C and D areas have a maximum interval of 12 months.

For UK sites, the MHRA requires manufacturer’s licence applicants to demonstrate compliance with EU GMP and subjects sites to GMP inspection. Energy projects should therefore involve engineering, production, quality assurance and validation before a control sequence changes.

BS EN ISO 14644-16:2019 provides the energy framework

Benchmark performance without weakening cleanroom control

BS EN ISO 14644-16:2019 addresses energy efficiency in new and existing cleanrooms, clean zones and separative devices. It covers design, construction, commissioning and operation. Its contribution is straightforward: benchmark energy performance while retaining the performance requirements of the ISO 14644 series.

Instead of asking whether a room has a high air-change rate, ask whether its current energy use delivers a defined and necessary contamination-control outcome. A room may have inherited airflow from a generic design guide, an earlier process configuration or a conservative commissioning allowance. These conditions often change during a facility’s life.

The standard directs attention to the whole cleanroom lifecycle:

• contaminant-source evaluation;
• user requirements specification;
• design, redesign and construction;
• testing;
• operation and maintenance; and
• decommissioning.

This structure supports a pharmaceutical energy audit without treating a cleanroom as a standard office air handling system.

Air-change rate is a result, not a default target

EU GMP Annex 1 does not prescribe a universal air-change rate for each room grade. Manufacturers must demonstrate that airflow and airflow pattern meet the room’s specified performance requirements. The required volume depends on the process, contamination sources, occupancy, room geometry, equipment layout, filtration arrangement, pressure relationships and recovery objective.

The 2019 cleanroom ventilation study examined fine-tuning airflow from measured particle concentration, demand-controlled filtration and improved airflow patterns. In one specific case-study setting, demand-controlled filtration produced energy reductions of up to 93.6%. This is not a forecast for other sites. It shows the energy penalty when airflow exceeds the level needed for the real contaminant source and operating state.

Facilities should establish the correct airflow through risk assessment, representative testing and qualification. Generic air-change figures can provide an initial design reference, but do not replace evidence from the installed room.

Where pharmaceutical HVAC energy efficiency opportunities sit

At-rest airflow reduction can cut fan energy

At-rest operation is often the first opportunity. Production schedules may leave a cleanroom unoccupied for long periods while the HVAC plant runs at operational airflow. A validated reduction during the at-rest state can reduce fan power, coil load and the volume of make-up air requiring treatment.

An ISPE design example illustrates the scale. Halving supply airflow during at-rest operation reduced total system pressure drop from 1,150 Pa to 670 Pa and fan power from 4.3 kW to 1.3 kW.

A suitable strategy uses coordinated supply and return control, pressure-differential monitoring and controlled transitions between modes. The pressure cascade must remain within approved limits throughout changeover, including door events and restart conditions.

Reduce avoidable pressure drop and air leakage

Filter selection and replacement strategy affect fan demand. Low-pressure-drop final filters may offer a useful life-cycle benefit where they meet specified filtration and integrity requirements. The review must include terminal layout, face velocity, available fan pressure, filter-loading profile and validation requirements.

Duct leakage also matters. Leakage from supply ductwork creates extra fan and conditioning demand. Leakage in extract systems can disturb air balance. Terminal housings, access doors, dampers, duct joints and room-envelope penetrations deserve attention during an audit, particularly in older facilities or where modifications have accumulated.

Air leakage between rooms can increase the outdoor-air volume required to maintain the pressure cascade. A well-sealed cleanroom envelope reduces unnecessary make-up air, but the pressure-control design must still accommodate door operation and the intended movement of people and materials.

Improve coil and heat-recovery performance

Coils should deliver required temperature and humidity conditions with the lowest practical pressure drop and without excessive reheating. An audit should identify coil fouling, valve hunting, unstable discharge-air control, inappropriate chilled-water temperatures and simultaneous heating and cooling.

Heat recovery can reduce heating demand where the process risk assessment supports it. Any proposal needs a clear assessment of contamination-transfer risk, pressure relationships, cleanability, maintenance access, failure modes and the quality impact of the recovery device. The energy case alone is insufficient in a GMP environment.

How to audit cleanroom HVAC without compromising GMP

Start with a room-by-room energy and quality baseline

A useful baseline joins HVAC energy data with cleanroom performance data. It should distinguish operational, at-rest, cleaning, line-clearance and shutdown conditions. A single annual kWh figure hides periods when fans run at full load without a corresponding process requirement.

EnerTherm Engineering’s seven-step audit methodology can structure this work from initial consultation through on-site assessment, data analysis, conservation-measure identification, report preparation, implementation support and ongoing measurement and verification. On-site work can combine power analysers, thermal imaging and ultrasonic leak detection with a review of airflows, pressures, temperatures, relative humidity, filter condition and maintenance history.

The audit record should answer four linked questions.

Turn measures into controlled change

The change package should define the rationale, risk assessment, revised control logic, alarms, acceptance criteria and test evidence. Installation qualification confirms the approved equipment and configuration. Operational qualification challenges the system through its intended operating range. Performance qualification confirms repeatable performance under relevant process conditions.

A facilities team should monitor fan energy, airflow, pressure differential, temperature, relative humidity, particle performance and recovery performance after implementation. Trend review catches drift in filters, dampers, sensors or control settings before the system loses its intended balance.

IPMVP-aligned measurement and verification gives the project an auditable energy result. It also provides evidence that savings arose from the intended HVAC measure rather than reduced production hours, seasonal weather or a temporary process change.

The practical priority for pharmaceutical facilities

Treat cleanroom HVAC as a qualified utility

Pharmaceutical cleanroom HVAC energy efficiency depends on matching airflow and conditioning effort to demonstrated process need. The largest opportunities usually sit in full-speed at-rest operation, inherited air-change assumptions, uncontrolled pressure losses, duct leakage, poor coil control and unnecessary conditioning of make-up air.

The work must proceed in the right sequence: establish the quality baseline, identify excess energy, assess contamination-control risk, implement through GMP change control, requalify as required, then verify both performance and savings.

---

This article reflects the independent analysis and editorial opinion of EnerTherm Engineering. Product names, trademarks, and brands mentioned belong to their respective owners. EnerTherm Engineering is not affiliated with, endorsed by, or a licensee of any third-party software or product mentioned unless explicitly stated.